Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624001137583
Ethics application status
Approved
Date submitted
14/05/2024
Date registered
20/09/2024
Date last updated
20/09/2024
Date data sharing statement initially provided
20/09/2024
Type of registration
Retrospectively registered
Titles & IDs
Public title
Effect Of Testosterone Supplements On Anemia And Quality Of Life Amongst Patients On Regular Hemodialysis
Query!
Scientific title
Effect Of Testosterone Replacement On Anemia And Quality Of Life Amongst Patients On Maintenance Hemodialysis
Query!
Secondary ID [1]
312923
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
End Stage Renal Disease
333708
0
Query!
Condition category
Condition code
Renal and Urogenital
330389
330389
0
0
Query!
Kidney disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Injection testosterone enanthate 250mg subcut will be given once fortnightly for 6 months
it will be administered by a dialysis nurse 30 mins after each dialysis session. Adherence would be ensured as it will be administered and documented by a dialysis nurse.
Query!
Intervention code [1]
328522
0
Treatment: Drugs
Query!
Comparator / control treatment
Injection normal saline 0.5ml subcut will be given once fortnightly for 6 months
it will be administered by a dialysis nurse 30 mins after each dialysis session. Adherence would be ensured as it will be administered and documented by a dialysis nurse.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
338153
0
any change in hemoglobin levels
Query!
Assessment method [1]
338153
0
Haemoglobin levels by running blood samples in automated hematology cbc analysers
Query!
Timepoint [1]
338153
0
Baseline and at every months upto 6 months following the intervention
Query!
Secondary outcome [1]
434721
0
Quality of life
Query!
Assessment method [1]
434721
0
Questionnaire base quality of life assessment utilizing WHOQOL-BREF
Query!
Timepoint [1]
434721
0
Baseline and at every month till 6 months following intervention
Query!
Eligibility
Key inclusion criteria
1. Patients diagnosed with end-stage renal disease (ESRD) requiring maintenance hemodialysis.
2. Patients with documented anemia, defined as haemoglobin levels < 10 g/dL
3. Patients with stable medical conditions, defined as absence of acute illness or major surgical procedures within the past three months.
4. Patients who have been on a stable hemodialysis regimen for at least three months prior to enrollment.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
80
Years
Query!
Query!
Sex
Males
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Patients with known hypersensitivity or contraindications to testosterone replacement therapy (TRT).
2. Patients with active malignancy, including prostate cancer.
3. Patients with uncontrolled hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg).
4. Patients with severe liver disease (e.g., cirrhosis) or severe hepatic dysfunction (e.g., Child-Pugh class B or C).
5. Patients with severe cardiac disease (e.g., congestive heart failure, recent myocardial infarction) or unstable cardiovascular conditions.
6. Patients with a history of thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism).
7. Patients with significant psychiatric illness or cognitive impairment that may affect their ability to participate in the study or provide informed consent.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
sealed opaque envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/05/2024
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
30/06/2024
Query!
Date of last data collection
Anticipated
1/01/2025
Query!
Actual
Query!
Sample size
Target
24
Query!
Accrual to date
Query!
Final
24
Query!
Recruitment outside Australia
Country [1]
26292
0
Pakistan
Query!
State/province [1]
26292
0
Query!
Funding & Sponsors
Funding source category [1]
316442
0
Hospital
Query!
Name [1]
316442
0
Pakistan Emirates Military Hospital
Query!
Address [1]
316442
0
Query!
Country [1]
316442
0
Pakistan
Query!
Primary sponsor type
Individual
Query!
Name
Dr Qurat Ul Ain Azam - Pak Emirates Military Hospital
Query!
Address
Query!
Country
Pakistan
Query!
Secondary sponsor category [1]
318612
0
None
Query!
Name [1]
318612
0
Query!
Address [1]
318612
0
Query!
Country [1]
318612
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
315234
0
Ethical Review Commitee, Pak Emirates Military Hospital, Rawalpindi
Query!
Ethics committee address [1]
315234
0
Pak Emirates Military Hospital , The Mall, Rawalpindi, 46000, Punjab, Pakistan.
Query!
Ethics committee country [1]
315234
0
Pakistan
Query!
Date submitted for ethics approval [1]
315234
0
02/10/2023
Query!
Approval date [1]
315234
0
05/10/2023
Query!
Ethics approval number [1]
315234
0
a/28/erc/598/23
Query!
Summary
Brief summary
My research focuses on relationship between testosterone replacement and its effects on anaemia and quality of life amongst patients on hemodialysis
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
134078
0
Dr Qurat Ul Ain Azam
Query!
Address
134078
0
Pak Emirates Military Hospital , The Mall, Rawalpindi, 46000, Punjab, Pakistan
Query!
Country
134078
0
Pakistan
Query!
Phone
134078
0
+923245105840
Query!
Fax
134078
0
Query!
Email
134078
0
[email protected]
Query!
Contact person for public queries
Name
134079
0
Qurat Ul Ain Azam
Query!
Address
134079
0
Pak Emirates Military Hospital , The Mall, Rawalpindi, 46000, Punjab, Pakistan
Query!
Country
134079
0
Pakistan
Query!
Phone
134079
0
+923245105840
Query!
Fax
134079
0
Query!
Email
134079
0
[email protected]
Query!
Contact person for scientific queries
Name
134080
0
Qurat Ul Ain Azam
Query!
Address
134080
0
Pak Emirates Military Hospital , The Mall, Rawalpindi, 46000, Punjab, Pakistan
Query!
Country
134080
0
Pakistan
Query!
Phone
134080
0
+923245105840
Query!
Fax
134080
0
Query!
Email
134080
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
22341
Ethical approval
[email protected]
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF